Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428763 | SCV000513008 | benign | not specified | 2015-03-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000457337 | SCV000557046 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000659585 | SCV000781424 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001179775 | SCV001344547 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001579696 | SCV002049968 | likely benign | not provided | 2021-09-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001179775 | SCV002676138 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003995960 | SCV004844908 | likely benign | Marfan syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579696 | SCV001808173 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579696 | SCV001932352 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579696 | SCV001970644 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004737466 | SCV005354068 | likely benign | FBN1-related disorder | 2019-02-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |